BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
8.6300
10-2月-25 16:45:00
15 分の遅延
株式
-0.0900
-1.03%
本日の幅
8.5300 - 8.8000
ISIN
N/A
ソース
NASDAQ
-
BioCryst to Present at Upcoming Investor Conferences
07 5 2024 07:00:22 提供 Nasdaq GlobeNewswire
-
BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update
06 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 5 2024 07:00:07 提供 Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
25 4 2024 09:45:08 提供 NetDania Notify
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
24 4 2024 09:54:30 提供 NetDania Notify
-
BioCryst to Report First Quarter 2024 Financial Results on May 6
22 4 2024 07:00:50 提供 Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
19 4 2024 11:04:56 提供 NetDania Notify
-
BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency
17 4 2024 04:30:39 提供 Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
05 4 2024 09:45:07 提供 NetDania Notify
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
04 4 2024 15:51:53 提供 NetDania Notify
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
03 4 2024 09:45:12 提供 NetDania Notify
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 4 2024 07:00:23 提供 Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
02 4 2024 12:00:22 提供 NetDania Notify
-
BioCryst to Present at Upcoming Investor Conferences
25 3 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
14 3 2024 13:48:51 提供 NetDania Notify
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 3 2024 07:01:47 提供 Nasdaq GlobeNewswire
-
BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones
26 2 2024 07:00:05 提供 Nasdaq GlobeNewswire
-
23 2 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
21 2 2024 16:01:58 提供 Nasdaq GlobeNewswire
-
BioCryst Launches ORLADEYO® (berotralstat) in Italy
19 2 2024 07:54:52 提供 Nasdaq GlobeNewswire